Radiotherapy as a bridging strategy for patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy

Am J Hematol. 2024 Sep;99(9):1837-1840. doi: 10.1002/ajh.27409. Epub 2024 Jun 11.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Female
  • Humans
  • Immunotherapy, Adoptive*
  • Lymphoma, Large B-Cell, Diffuse* / radiotherapy
  • Lymphoma, Large B-Cell, Diffuse* / therapy
  • Male
  • Middle Aged
  • Receptors, Chimeric Antigen / therapeutic use

Substances

  • Receptors, Chimeric Antigen